21 – 30 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Regulatory responses to medical machine learning
- Contribution to journal › Article
-
Mark
The EU-US Privacy Shield Regime for Cross-Border Transfers of Personal Data under the GDPR: What are the legal challenges and how might these affect cloud-based technologies, big data, and AI in the medical sector?
- Contribution to journal › Article
-
Mark
Establishing the First International Genetic Discrimination Observatory
- Contribution to journal › Article
-
Mark
Clinical trial data transparency and GDPR compliance: Implications for data sharing and open innovation
(2020) In Science and Public Policy
- Contribution to journal › Article
-
Mark
One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?
- Contribution to journal › Article
-
Mark
Preparing for antimicrobial resistance in the wake of the COVID-19 pandemic: The vision and “social science” mission of the INAMRSS network
(2020)
- Other contribution › Web publication
-
Mark
An EU Comparative Analysis of the Regulation of Clinical Trials Supervisory Bodies in the Aftermath of Regulation 536/2014
- Contribution to journal › Article
- 2019
-
Mark
Nudges or Shoves in the Secondary Use of Health Data: What is the More Desirable Approach? (Part 2)
(2019)
- Other contribution › Miscellaneous
-
Mark
How does emerging patent case law in the US and Europe affect precision medicine?
- Contribution to journal › Article
-
Mark
Nudges or Shoves in the Secondary Use of Health Data: What is the More Desirable Approach? (Part I)
(2019)
- Other contribution › Miscellaneous
